HMGB3 and ovarian carcinoma: Moreover, the clinicopathological characteristic analysis found that HMGB3-High was associated with lymph node metastasis and platinum resistance in HGSOC patients (Table 1), indicating that HMGB3 might play a vital role in the development of chemoresistance in ovarian cancer.